We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge-org.demo.remotlog.com
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Coronaviruses (CoV), including SARS CoV, are single-stranded RNA viruses and belong to the family Coronaviridae.
Epidemiology
Route of spread
Coronaviruses are spread by the respiratory route.
Severe acute respiratory syndrome (SARS) is caused by SARS coronavirus (SARS CoV), which is spread by the respiratory route and through the ingestion of aerosolized faeces via contamination of the hands and environment. Close contact with a symptomatic person poses the highest risk of infection. In the 2003 outbreak, most cases occurred in hospital workers or family members in contact with cases.
Prevalence
Coronaviruses have a worldwide distribution and almost all adults in the UK have been infected by at least one type of coronavirus. Infection usually occurs in winter or spring and is associated with upper respiratory tract infection (a ‘cold’). The severity of illness is similar to that of rhinovirus infection, but less severe than infection with respiratory syncitial virus or influenza viruses. Symptoms are usually more severe in elderly persons. Reinfection is common.
SARS CoV caused a worldwide outbreak between March and July 2003, and there was a smaller outbreak, probably associated with laboratory-released SARS CoV, in 2004. There were over 8000 cases reported from 32 countries. There have been no more cases since then. The outbreak originated in Guandong Province in China and is thought to have been transmitted from civet cats (a variety of wild cat) to humans with subsequent human-to-human spread.
By
Stanley Perlman, Department of Microbiology, University of Iowa, Iowa City, IA, USA,
Noah Butler, Department of Microbiology, University of Iowa, Iowa City, IA, USA
Mouse hepatitis virus (MHV) is a member of the Coronaviridae family in the order Nidovirales. Coronaviruses are classified into one of three antigenic groups, with MHV classified as a member of group 2 [1]. Members of the Coronaviridae family infect a wide range of species including humans, cows, pigs, chickens, dogs, cats, bats, and mice. In addition to causing clinically relevant disease in humans ranging from mild upper respiratory infection (e.g., HCoV [human coronavirus]-OC43 and HCoV-229E responsible for a large fraction of common colds) to severe acute respiratory syndrome (SARS) [2, 3], coronavirus infections in cows, chickens, and pigs exact a significant annual economic toll on the livestock industry.
MHV is a natural pathogen of mice that generally is restricted to replication within the gastrointestinal tract [4, 5]. However, there exist several laboratory strains of MHV that have adapted to replicate efficiently in the central nervous system (CNS) of mice and other rodents. Depending on the strain of MHV, virulence and pathology ranges from mild encephalitis with subsequent clearance of the virus and the development of demyelination to rapidly fatal encephalitis. Thus, the neurotropic strains of MHV have proved to be useful systems in which to study processes of virus- and immune-mediated demyelination, virus clearance and/or persistence in the CNS, and mechanisms of virus evasion from the immune system.
Neurotropism and neuroinvasiveness have also has been described for two other members of the Coronaviridae family, HCoV-OC43 and SARS-coronavirus (CoV) (Table 4.1).
By
Chi Wai Leung, Consultant Pediatrician and Chief of Pediatric Infectious Diseases, Princess Margaret Hospital, Lai Chi Kok, Kowloon, Hong Kong,
Thomas S. T. Lai, Consultant and Chief of Infectious Disease, Department of Medicine and Geriatrics, Princess Margaret Hospital, Lai Chi Kok, Kowloon, Hong Kong
Edited by
Rachel L. Chin, University of California, San Francisco
Severe acute respiratory syndrome (SARS) is an often fatal infectious respiratory disease with prominent systemic symptoms. It is caused by a novel coronavirus, SARS coronavirus (SARS-CoV), which was responsible for a global outbreak from November 2002 to July 2003. SARS-CoV probably has its origin in Southern China and is a zoonosis that initially affected wild animals, possibly bats, and subsequently spread to exotic animals. The virus can be identified by reverse transcriptase polymerase chain reaction (RT-PCR) in blood, plasma, respiratory secretions, and stool. Specific antibody is detected in acute and convalescent sera from patients by indirect fluorescent antibody (IFA) testing and enzyme-linked immunosorbent assay (ELISA) targeting the surface spike (S) protein.
EPIDEMIOLOGY
During the 2002–2003 SARS outbreak, a cumulative total of 8096 probable cases, with 774 deaths, were reported from 29 countries and areas. A global case-fatality rate of 9.6% was recorded at the end of the outbreak. The total number of health care workers affected was 1706 (21.1% of all probable cases). Interestingly, the severity of the syndrome appears to have been greater in adults and adolescents than in young children. No mortality was reported in children worldwide.
The incubation period of SARS generally ranged from 2 to 10 days. The primary mode of transmission appears to be direct mucous membrane (eyes, nose, and mouth) contact with infectious respiratory droplets and/or through exposure to fomites.
Bovine torovirus (BoTV) is a pleomorphic virus with a spike-bearing envelope and a linear, non-segmented, positive-sense single-stranded RNA genome. This kidney-shaped virus is associated with diarrhea in calves and apparently has a worldwide distribution. This review provides details of the history and taxonomy of BoTV since its discovery in 1979. Information about virion morphology and architecture, antigenic and biological properties, viral genome, protein composition, thermal and chemical stability, and pH and proteolytic enzymes resistance is also summarized. A major focus of this review is to postulate a possible epidemiological cycle for BoTV, based on epidemiological data obtained in our studies and other published data, and progressing from the newborn calf to the adult animal. The distribution, host range, pathogenesis, disease and clinical signs (under experimental and natural exposure), pathology, diagnosis, prevention, treatment and control of BoTV infections are also described. In addition, a discussion of the zoonotic implications of torovirus-like particles detected in patients with gastroenteritis that resemble and cross-react with BoTV is presented. Hopefully, the findings described here will alert others to the existence of BoTV in cattle and its contribution to the diarrheal disease complex. This review also highlights the need for continual vigilance for potential zoonotic viruses belonging to the order Nidovirales, such as the SARS coronavirus.
To evaluate the risk of transmission of SARS coronavirus outside of the health-care setting, close household and community contacts of laboratory-confirmed SARS cases were identified and followed up for clinical and laboratory evidence of SARS infection. Individual- and household-level risk factors for transmission were investigated. Nine persons with serological evidence of SARS infection were identified amongst 212 close contacts of 45 laboratory- confirmed SARS cases (secondary attack rate 4·2%, 95% CI 1·5–7). In this cohort, the average number of secondary infections caused by a single infectious case was 0·2. Two community contacts with laboratory evidence of SARS coronavirus infection had mild or sub-clinical infection, representing 3% (2/65) of Vietnamese SARS cases. There was no evidence of transmission of infection before symptom onset. Physically caring for a symptomatic laboratory-confirmed SARS case was the only independent risk factor for SARS transmission (OR 5·78, 95% CI 1·23–24·24).
This study used a sensitive polymerase chain reaction method coupled with filter sampling to detect the presence of airborne severe acute respiratory syndrome (SARS) coronavirus in an isolation patient room with a patient with severe acute respiratory syndrome receiving mechanical ventilatory support. Polymerase chain reaction results were negative for SARS coronavirus in room air both before and after patient extubation.
We systematically reviewed the current understanding of human population immunity against SARS-CoV in different groups, settings and geography. Our meta-analysis, which included all identified studies except those on wild animal handlers, yielded an overall seroprevalence of 0·10% [95% confidence interval (CI) 0·02–0·18]. Health-care workers and others who had close contact with SARS patients had a slightly higher degree of seroconversion (0·23%, 95% CI 0·02–0·45) compared to healthy blood donors, others from the general community or non-SARS patients recruited from the health-care setting (0·16%, 95% CI 0–0·37). When analysed by the two broad classes of testing procedures, it is clear that serial confirmatory test protocols resulted in a much lower estimate (0·050%, 95% CI 0–0·15) than single test protocols (0·20%, 95% CI 0·06–0·34). Potential epidemiological and laboratory pitfalls are also discussed as they may give rise to false or inconsistent results in measuring the seroprevalence of IgG antibodies to SARS-CoV.
Between March and July 2003, 671 cases of severe acute respiratory syndrome (SARS) were diagnosed in Taiwan with a total of 84 fatalities. After the epidemic, a serological survey was conducted involving the asymptomatic household contacts. Household contacts of 13 index patients were enrolled in the study. Contact history and clinical symptoms of the household contacts were recorded by standardized questionnaires. Blood samples of patients and household contacts were collected at least 28 days after symptom onset in the index patients or household exposure in the contacts for SARS-associated coronavirus (SARS-CoV) IgG testing. On the basis of this investigation, 29 persons (25 adults and 4 children) were identified as having had unprotected exposure to the index cases before infection-control practices were implemented. Laboratory evaluation of clinical specimens showed no evidence of transmission of SARS-CoV infection to any contacts. This investigation demonstrated that subclinical transmission among household contacts was low in the described setting.
Three outbreaks of respiratory illness associated with human coronavirus HCoV-OC43 infection occurred in geographically unrelated aged-care facilities in Melbourne, Australia during August and September 2002. On clinical and epidemiological grounds the outbreaks were first thought to be caused by influenza virus. HCoV-OC43 was detected by RT–PCR in 16 out of 27 (59%) specimens and was the only virus detected at the time of sampling. Common clinical manifestations were cough (74%), rhinorrhoea (59%) and sore throat (53%). Attack rates and symptoms were similar in residents and staff across the facilities. HCoV-OC43 was also detected in surveillance and diagnostic respiratory samples in the same months. These outbreaks establish this virus as a cause of morbidity in aged-care facilities and add to increasing evidence of the significance of coronavirus infections.
We attempted to detect the presence of airborne SARS-coronavirus (CoV) in a healthcare setting when a patient with SARS used a humidifier or a large-volume nebulizer (LVN). All of the air samples from the humidifier and LVN were found to have negative SARS-CoV-specific DNA products.
To rapidly establish a temporary isolation ward to handle an unexpected sudden outbreak of severe acute respiratory syndrome (SARS) and to evaluate the implementation of exposure control measures by healthcare workers (HCWs) for SARS patients.
Design:
Rapid creation of 60 relatively negative pressure isolation rooms for 196 suspected SARS patients transferred from 19 hospitals and daily temperature recordings of 180 volunteer HCWs from 6 medical centers.
Setting:
A military hospital.
Results:
Of the 196 patients, 34 (17.3%) met the World Health Organization criteria for probable SARS with positive results of serologic testing for SARS-associated coronavirus (SARS-CoV), reverse transcriptase polymerase chain reaction (RT-PCR) from nasopharyngeal or throat swabs for SARS-CoV, or both. Seventy-four patients had suspected SARS based on unprotected exposure to SARS patients; three of them had positive results on RT-PCR but negative serologic results. The remaining 88 patients did not meet the criteria for a probable or suspected SARS diagnosis. Of the 34 patients with probable SARS, 13 were transferred to medical centers to receive mechanical ventilation due to rapid deterioration of chest x-ray results, and three patients died of SARS despite intensive therapy in medical centers. During the study period, one nurse developed probable SARS due to violation of infection control measures, but there was no evidence of cross-transmission to other HCWs.
Conclusions:
Despite the use of full personal protection equipment, the facility failed to totally prevent exposures of HCWs to SARS but minimized the risk of nosocomial transmission. Better training and improvements in infection control infrastructure may limit the impact of SARS.
To help facilities prepare for potential future cases of severe acute respiratory syndrome (SARS).
Design and Participants:
The Centers for Disease Control and Prevention (CDC), assisted by members of professional societies representing public health, healthcare workers, and healthcare administrators, developed guidance to help facilities both prepare for and respond to cases of SARS.
Interventions:
The recommendations in the CDC document were based on some of the important lessons learned in healthcare settings around the world during the SARS outbreak of 2003, including that (1) a SARS outbreak requires a coordinated and dynamic response by multiple groups; (2) unrecognized cases of SARS-associated coronavirus are a significant source of transmission; (3) restricting access to the healthcare facility can minimize transmission; (4) airborne infection isolation is recommended, but facilities and equipment may not be available; and (5) staffing needs and support will pose a significant challenge.
Conclusions:
Healthcare facilities were at the center of the SARS outbreak of 2003 and played a key role in controlling the epidemic. Recommendations in the CDC's SARS preparedness and response guidance for healthcare facilities will help facilities prepare for possible future outbreaks of SARS.
Patients infected by severe acute respiratory syndrome (SARS) require imaging during the course of their disease. Plain radiography and computed tomography (CT) will be employed routinely, although during an epidemic all imaging modalities may be requested at some point. Infection control is concerned with protecting the individual against infection and containing an outbreak, at the same time as providing medical care for those patients with SARS. In a radiology department it is, of course, of utmost importance that the staff are protected, but for those centres that also have to maintain essential services for patients without SARS, there is the additional consideration of preventing cross infection between patients. When planning control measures against any infection, details of the mode of infection. Transmission must be taken into account, for the SARS coronavirus the important points to take into consideration are shown in Table 15.1. The format of this chapter may appear laborious, but it is designed to provide practical checklists covering some of the most important issues that need to be considered when preparing a department for the battle against infection.
Infection control measures to be taken by staff
Staff education
This is one of the most important aspects of infection control:
All staff must be fully aware of the infection control guidelines of the department and hospital, and should be trained in infection control measures before entering any high-risk area.
Severe acute respiratory syndrome (SARS) is a newly emerged disease caused by a previously unknown coronavirus. It joins a long list of emerging infections. However, unlike other contenders such as avian influenza, Nipah virus, Hendra virus or hantaviruses it has established the capacity for efficient human-to-human transmission and thus poses a major threat to international public health. For this reason, the World Health Organisation (WHO) has described SARS as the first serious and readily transmissible disease to emerge in the 21st century.
The first known cases of SARS occurred in Guangdong Province in southern China in late November 2002. The first official report of an outbreak of atypical pneumonia in the province on 11 February 2003 indicated that the disease had affected 305 persons and caused five deaths, and that around 30% of cases had occurred in health care workers. On 21 February 2003, a medical doctor infected with SARS travelled from Guangzhou, the provincial capital, and stayed one night at a hotel in Hong Kong. He infected at least 16 other guests and visitors in the hotel. Within days, the disease began spreading around the world along international air travel routes as hotel contacts seeded hospital outbreaks in Hong Kong, Vietnam, Singapore and Canada (Figure 1.1).
Severe acute respiratory syndrome (SARS) is a newly emerged disease and the epidemic in Hong Kong came as a crisis. The clinical course of SARS appears to follow a triphasic pattern: phase I is clinically characterized by fever, myalgia and other systemic symptoms that generally improve after a few days. This is the phase when active viral replication occurs. Phase II is characterized by recurrence of fever, oxygen desaturation and radiological progression of pneumonia. The clinical progression during phase II appears to be related to immuno-pathological damage. The majority of patients recovered spontaneously but in some the disease progressed into phase III, characterized by acute respiratory distress syndrome (ARDS) necessitating ventilatory support (Figure 9.1). Reports show that with the development of respiratory failure and ARDS, 15–30% of patients will require intensive care admission.
Histological examination shows the presence of coronavirus particles in the alveoli of the infected lungs. Histopathology of post-mortem cases also reveal diffuse alveolar damage, pulmonary oedema, hyaline membrane formation and highly activated macrophages with haemophagocytosis. Thus, the treatment modalities should include antivirals, immuno-modulators and respiratory support at the different stages of the diseases.
Severe acute respiratory syndrome (SARS) has emerged as a new respiratory disease caused by a novel coronavirus and is associated with substantial morbidity and mortality [1, 2]. Dynamic mathematical models have suggested that SARS, if uncontrolled, would infect the majority of people wherever it was introduced [3–5]. The patterns of spread suggest droplet or contact transmission [6]. Close proximity of persons enhances the risk of transmission, and this together with handling of human secretions (respiratory secretions, faeces, etc.) have made the hospital setting particularly vulnerable to the rapid spread of SARS.
THE treatment of fractures and dislocations is one of the oldest forms of surgical handicraft, and the influence of many of the principles and procedures expounded in such clear detail in the corpus of Hippocratic texts can be witnessed in the practice of casualty surgery at the present day. Thus Hippocrates taught the importance of the early reduction of deformity, and the value of continued traction as a means of maintaining correct alignment of the limb. But despite the antiquity of the theoretical knowledge thus available, every young surgeon in his turn, when first confronted with responsibility for the ‘setting’ of fractures, has to acquire his own sense of manipulative skill, usually by the process of trial and error. In this stimulating monograph Mr Charnley has sought to illuminate some of the obscurities of the mechanics of fracture treatment, and he has succeeded, in a most vivid fashion, in creating by means of text and illustration a series of mental pictures—a frame of reference, so to say—whereby the young surgeon can get the ‘feel’ of a fracture; first the anatomy of the displacement, and then that confident ‘clinical sense’ of precise correction of the deformity which follows a skilful manipulative act of reduction. Mr Charnley has also incorporated in this book his original observations on the genesis and prevention of joint stiffness; his well-known ingenious work on the design and uses of the walking caliper; and not least in importance, an invaluable chapter in which he presents a critical study of the various types of modern plaster-of-Paris technique.
The treatment of fractures of the shaft of the femur is of particular interest, demonstrating as it does certain fundamental fracture mechanics previously described in more general terms. It seems probable that new operative methods of treating the fractured femur—such as the medullary nail of Kuntscher—will in the future take precedence over closed methods for transverse fractures of the shaft (which are always difficult to handle by conservative means) and for most other fractures in the middle and upper thirds. For fractures of the femur in the distal third which have been successfully reduced I believe that Thomas5 method is unrivalled.
One of the many lessons we can learn from this fracture is the danger of becoming too much engrossed in minutiae, if by so doing we lose the broad view of a problem. This is an error into which the tempo of modern life makes it easy to fall. We must never lose sight of two facts: firstly, that a fracture of the shaft of a femur can often be the easiest of fractures to treat conservatively; and secondly, that full recovery after a fracture of the femur takes about one year (which is the time necessary for full reconstruction of the ivory shaft of this bone). These are facts which we tend to forget when assessing new methods which apparently offer quick dividends and short hospitalisation. Procedures adopted in the early phases of treatment can sometimes have disappointing and unexpected repercussions at a later date.
The injuries specially to be considered under this heading are: (i) T-shaped ir, the tibial plateau, and (4) depressed I supracondylar fractures of the femur, (2) fractures of the medial femoral condyle, (3) T-shaped fractures of th fractures of the lateral tibial condyle.
The principles which should dominate treatment must take into account the following three features:
They are fractures involving a joint.
They are fractures of cancellous bone and are either comminuted or impacted.
They occur commonly in elderly patients and only rarely in athletic age groups.
These features demand a method with the following requirements:
Early mobilisation because the joint is involved.
Avoidance of traction and the encouragement of ‘controlled collapse.’ Controlled collapse in fractures of cancellous bone favours rapid consolidation and therefore indirectly promotes the return of joint mobility.
Acceptance of radiological deformity if clinical deformity is not gross. This is often made possible by the patient's age and is part of the principle of ‘controlled collapse.’
When these principles are observed the rate of consolidation and recovery of joint mobility in elderly patients is sometimes quite astonishing. It is no uncommon thing to find a fracture quite painless at three weeks under this regime. In the patient, aged eighty-one, illustrated in Fig. 152, the T-shaped supracondylar fracture of the lower end of the femur was treated on a Thomas splint with fixed traction. While permitting collapse of the fracture from its original position after reduction the shortening became excessive (Fig. 153).